Evidence map›Paper›PMID 42804938›Full record

ArticleClinics (Sao Paulo, Brazil)2026

Association between lipid accumulation product and the prevalence of peripheral artery disease: A cross-sectional study based on NHANES 1999‒2004.

Ling-Bin Mi, A-Bing Li

Abstract read
In one paragraph

Article in Clinics (Sao Paulo, Brazil), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ling-Bin MiDepartment of Orthopedics, Ningbo Hospital of Integrated Traditional Chinese and Western Medicine, Ningbo, China.
A-Bing LiDepartment of Orthopedics, Ningbo Hospital of Integrated Traditional Chinese and Western Medicine, Ningbo, China. Electronic address: bing19890807@hotmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study aimed to evaluate the association between Lipid Accumulation Product (LAP) and the prevalence of Peripheral Artery Disease (PAD) among US adults using nationally representative data from the National Health and Nutrition Examination Survey (NHANES).

methodsData from NHANES conducted between 1999 and 2004 were utilized for this analysis. Survey-weighted logistic regression models were used to examine the association between Log-transformed LAP (Ln-LAP) and PAD prevalence, with Ln-LAP analyzed both as a continuous variable and according to tertiles. Restricted cubic spline analysis was performed to assess the dose-response relationship. Prespecified subgroup analyses and exploratory machine-learning analyses using random forest and Light Gradient Boosting Machine models were also conducted.

resultsAmong 5,202 participants, 287 had PAD. The findings indicate a significant positive association between the natural logarithm of LAP (Ln-LAP) and the prevalence of PAD. After adjustment for potential confounders, each one-unit increase in Ln-LAP was associated with 36% higher odds of prevalent PAD (OR = 1.36, 95% CI 1.18-1.58). Notably, this association is particularly pronounced in specific subgroups, including women, individuals with estimated Glomerular Filtration Rate (eGFR) less than 60 mL/min/1.73 m

conclusionOur study suggests a notable positive association between LAP levels and the prevalence of PAD. The association appeared to be approximately linear and may be more pronounced in specific subgroups. Given the cross-sectional design, causal inference cannot be made.

Indexed as

Ankle-brachial indexLipid accumulation productNational health and nutrition examination surveyPeripheral artery disease

Identifiers

PMID42804938
PMCPMC13653477

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.